SCHEMBL6979036

SCHEMBL6979036

O=C1CCN(c2ccc(Cl)cc2)c2ccc(Cl)cc21

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 7/20 0.47
VHL P40337 1/20 0.41
ELOC Q15369 1/20 0.41
ELOB Q15370 1/20 0.41
KMT2A Q03164 1/20 0.41
BRD4 O60885 2/20 0.40
BRD2 P25440 1/20 0.40
BRD3 Q15059 1/20 0.40
SMARCA2 P51531 1/20 0.39
ALOX5 P09917 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
HTR2B P41595 1/20 0.39
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL69760 0.77 OPRK1 (0.48) SRD5A1VHLELOCELOBKMT2A
SCHEMBL8415245 0.75 CYP3A4 (0.39) KMT2ABRD4LMNA
SCHEMBL11139328 0.74 VHL (0.41) SRD5A1VHLELOCELOBKMT2A
SCHEMBL10493802 0.73 SRD5A1 (0.46) SRD5A1KMT2AKDM4EALDH1A1LMNA
SCHEMBL11141196 0.73 NOTUM (0.48) SRD5A1VHLELOCELOBKMT2A
SCHEMBL2704794 0.73 KMT2A (0.56) KMT2A
SCHEMBL11147651 0.72 NOTUM (0.66)
SCHEMBL9538299 0.72 ALDH1A1 (0.49) SRD5A1VHLELOCELOBKMT2A
SCHEMBL7666520 0.71 VHL (0.42) SRD5A1VHLELOCELOBKMT2A
SCHEMBL7664010 0.71 SRD5A1 (0.41) SRD5A1VHLELOCELOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed